Related Experiment Video
Updated: Jul 14, 2026
08:34
The Measurement and Treatment of Suppression in Amblyopia
Published on: December 14, 2012
Modeling dose-response in amblyopia: toward a child-specific treatment plan
Catherine E Stewart1, David A Stephens, Alistair R Fielder
1Department of Optometry and Visual Science, City University, London, United Kingdom. c.e.stewart@city.ac.uk
Investigative Ophthalmology & Visual Science
|May 26, 2007
Summary
This study models occlusion therapy for amblyopia, finding that increased patching time improves visual acuity. Treatment effectiveness is age-dependent, with older children needing more patching hours for similar visual gains.
Area of Science:
- Ophthalmology
- Pediatric Medicine
- Biostatistics
Background:
- Amblyopia, or
- lazy eye
- is a common cause of reduced vision in children.
- Occlusion therapy, involving patching the stronger eye, is a primary treatment.
- Understanding the dose-response relationship is crucial for effective treatment.
Purpose of the Study:
- To develop a mathematical model for occlusion therapy dose-response in amblyopia.
- To analyze outcome data from the Monitored Occlusion Treatment for Amblyopia Study (MOTAS).
Main Methods:
- Utilized data from the occlusion phase of the MOTAS protocol.
- Included 72 children aged 3-8 years with amblyopia due to anisometropia, strabismus, or both.
- Employed an occlusion dose monitor (ODM) to objectively track patching duration (6 hours/day).
Main Results:
- Linear regression showed a strong correlation (R2 = 0.918) between cumulative patching hours and visual acuity improvement.
- Optimal visual acuity was achieved with 150-250 cumulative patching hours for most children.
- Age significantly influenced the dose-response; older children required more patching hours for equivalent visual gains.
Conclusions:
- Mathematical modeling provides novel insights into the kinetics of amblyopia treatment response.
- The age-dependent response highlights altered visual system plasticity in older children.
- This model supports the development of personalized, evidence-based treatment plans for amblyopia.
Related Concept Videos
01:21Dose Response Curve: Conventional Versus Nonmonotonic
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...
01:03Dose-Response Relationship: Overview
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:22Dose-Response Relationship: Potency and Efficacy
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...